Ikarian Capital, LLC Iveric Bio, Inc. Call Options Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$9.4 - $18.59 $1.82 Million - $3.6 Million
193,500 Added 79.17%
437,900 $7.86 Million
Q2 2022

Aug 12, 2022
BUY
$9.12 - $18.9 $404,927 - $839,159
44,400 Added 22.2%
244,400 $2.35 Million
Q3 2021

Nov 15, 2021
BUY
$7.07 - $17.5 $1.41 Million - $3.5 Million
200,000 New
200,000 $3.25 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email